CDMOHUBCDMOHUB
Pricing
    CDMOHUBCDMOHUB
    Pricing
    CDMOHUBCDMOHUB
    Pricing
    CDMOHUBCDMOHUB
    Pricing
    1. Home
    2. /CDMOs
    3. /Delpharm
    Delpharm logo

    Delpharm

    CDMO
    Canada
    https://www.delpharm.com/en/

    Is this your company? Claim this profile

    Drug Product
    Analytical & Bioanalytical Services
    Regulatory, Tech Transfer & Support Services
    Clinical Trial Supply & Logistics
    Contract Research Organization
    Drug Substance
    Company Overview

    About

    Delpharm is one of the world's top five CDMOs, specializing in the development and manufacture of medicines across solid, sterile, semi-solid, and liquid dosage forms with particular expertise in nasal sprays and injectables. The company operates 18 manufacturing sites and 3 development centers across Europe and North America, with 6,500 employees and over 1.1 billion EUR in turnover. Delpharm produces over 650 million units annually and recently received a $60 million Canadian government investment to modernize its Boucherville injectable facility.

    Key Expertise

    Nasal spray manufacturing, sterile fill/finish, prefilled syringes, solid dose, semi-solid forms, blow-fill-seal, high potent drugs

    Quick Facts
    HQ:Canada
    Capabilities & Services

    Core Capabilities

    • Small Molecule Drug Product
    • Oral Solid Dose
    • Formulation Development

    Dosage Forms

    Oral Solid Dose
    Sterile Injectable
    Lyophilized (Freeze-Dried)
    Prefilled Syringe
    Topical / Transdermal
    Inhalation

    Production Scales

    R&D / Pre-clinical
    Clinical
    Commercial Scale

    Annual Capacity

    Commercial (1,000 - 10,000 kg/year)
    Large Commercial (> 10,000 kg/year)

    Markets Served

    Europe
    North America
    Manufacturing Facilities

    5 sites worldwide

    Delpharm - Canada Facility

    Canada
    View on Map

    Site Capabilities

    3 capabilities
    Gene Therapy
    Cell Therapy
    mRNA

    Delpharm - France Facility

    France
    View on Map

    Site Capabilities

    3 capabilities
    Gene Therapy
    Cell Therapy
    mRNA

    Delpharm - Italy Facility

    Italy
    View on Map

    Site Capabilities

    3 capabilities
    Gene Therapy
    Cell Therapy
    mRNA

    Delpharm - Netherlands Facility

    Netherlands
    View on Map

    Site Capabilities

    3 capabilities
    Gene Therapy
    Cell Therapy
    mRNA

    Delpharm - Poland Facility

    Poland
    View on Map

    Site Capabilities

    3 capabilities
    Gene Therapy
    Cell Therapy
    mRNA
    Certifications

    FDA Registration

    U.S. Food and Drug Administration

    EMA GMP Certificate

    European Medicines Agency
    Request an Introduction

    Please log in to contact this provider.

    Key facts about Delpharm

    • Delpharm is headquartered in Canada.
    • Delpharm has 5 manufacturing sites listed on CDMO Hub, in Canada, France, Italy, the Netherlands and Poland.
    • Delpharm's capabilities include Small Molecule Drug Product, Oral Solid Dose and Formulation Development.

    Find CDMOs like Delpharm

    Directory pages this company appears in, each with the full list of matching manufacturers.

    CDMOs in CanadaCDMOs in North AmericaSmall Molecule Drug Product CDMOsOral Solid Dose CDMOsFormulation Development CDMOsOral Solid Dose CDMOsSterile Injectable CDMOsLyophilized (Freeze-Dried) CDMOsPrefilled Syringe CDMOs
    CDMOHUB

    Connecting biotech and pharma teams with contract manufacturing partners worldwide.

    Platform

    • Find CDMOs
    • CDMO Matchmaking
    • Expert Matchmaking
    • SmartRFI
      Members
    • Modality Guides
    • Supplier Maps
    • Join as Partner

    Company

    • Blog
    • Briefings
    • About Us
    • Contact

    Legal

    • Terms of Service
    • Privacy Policy

    © 2026 CDMOHUB. All rights reserved.

    CDMO Hub, Inc. Registered in Delaware, USA